Boston Sci Buys Asthma Treatment Maker For $443M

Law360, New York (September 20, 2010, 2:33 PM EDT) -- Medical device maker Boston Scientific Corp. said Monday that it would pay up to $443.5 million to acquire privately held Asthmatx Inc., which produces and markets a recently approved nondrug treatment for severe asthma.

The deal calls for Boston Scientific to make an up-front payment of $193.5 million and additional payments of up to $250 million through 2019 if certain revenue-based goals are met. The deal is expected to close in the fourth quarter, subject to customary conditions, Boston Scientific said.

Sunnyvale, Calif.-based Asthmatx markets the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.